Open Access Case Report

Covid-19 Acute Respiratory Distress Syndrome And Acute Myocarditis Saved With Immunoglobulin

Jebbar Nourddine1,3*, Elkaissi Jaber1,3, Diai Abdellatif1,3, Maaroufi Ayoub1,3, Jbili Nabil1,3, Bibiche Lotfi1,3, Zinebi Ali2,3 and Laoutid Jaouad1,3

1Anesthesiology & intensive care department, Moulay Ismail Military Hospital, Morocco.

2Internal Medicine Department, Moulay Ismail Military Hospital, Morocco.

3Faculty of Medicine, Sidi Mohamed Ben Abdellah University, Morocco.

Corresponding Author

Received Date: February 07, 2021;  Published Date:February 22, 2021

Abstract

The novel corona virus disease (COVID-19) becomes a major public health. It was declared as pandemic by the World Health Organization on March 12, 2020.Myocarditis and myocardial injury are considered as one of the leading causes for death of COVID-19 Patients. The use of immunoglobulin seems to have an important role in the favorable evolution of these patients with cardiac involvement.

Citation
Signup for Newsletter
Scroll to Top